SCHEMBL62175

SCHEMBL62175

NCCCOCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6051828 0.97 ODC1 (0.47)
SCHEMBL3379427 0.97 ODC1 (0.47)
SCHEMBL2614685 0.97 ODC1 (0.47)
SCHEMBL23779684 0.97 ODC1 (0.47)
SCHEMBL10796626 0.97 ODC1 (0.47)
SCHEMBL23779679 0.97 ODC1 (0.47)
SCHEMBL15259801 0.94 ODC1 (0.45)
SCHEMBL17110675 0.94 ODC1 (0.45)
SCHEMBL3443840 0.94 ODC1 (0.45)
SCHEMBL64659 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346966-A1 MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY DYNE THERAPEUTICS, INC. (US) 2023-11-02 US disclosed
US-20230285582-A1 MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY DYNE THERAPEUTICS, INC. (US) 2023-09-14 US disclosed
US-20230226212-A1 MUSCLE-TARGETING COMPLEXES AND USES THEREOF DYNE THERAPEUTICS, INC. (US) 2023-07-20 US disclosed
US-20230190951-A1 CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERS SYNAFFIX B.V. (NL) 2023-06-22 US disclosed
US-20230165780-A1 CROSSLINKED MATERIALS FOUNT BIO, INC. 2023-06-01 US disclosed
US-20230035986-A1 NOVEL CROSSLINKED ALGINIC ACID MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2023-02-02 US disclosed
EP-4118161-A1 USE OF SPECIFIC OPEN-CHAIN ETHER ISOCYANATES Covestro Deutschland AG (DE) 2023-01-18 EP disclosed
US-20230010508-A1 COMPOUND COMPRISING EZH2 INHIBITOR AND E3 LIGASE BINDER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EZH2-ASSOCIATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) 2023-01-12 US disclosed
WO-2021261712-A1 HEMOGLOBIN DERIVATIVE CO-CONJUGATED WITH FATTY ACID-LINKED PEG AND ALKOXY PEG AS A BLOOD SUBSTITUTE SUNBIO, INC. (KR) 2021-12-30 WO disclosed
US-20210371714-A1 ADHESIVE FOR ENDOSCOPE, CURED PRODUCT THEREOF, ENDOSCOPE, AND METHOD FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2021-12-02 US disclosed
US-6320064-B1 SURFACTANTS FOR AQUEOUS CLEANER SYSTEMS FOR CLEANING NONTEXTILE MATERIAL WITH IMPROVED FAT-REMOVAL CAPACITY BASF AKTIENGESELLSCHAFT (DE) 2001-11-20 US disclosed
US-6204238-B1 BASED ON EPOXIDIZED UNSATURATED FATTY ACID ESTERS OR TRIGLYCERIDES AND REACTED WITH AMINES SUCH AS HYDROXY-AND/OR AMINO-SUBSTITUTED HYDROPHILIC AMINES OR AMINO ACIDS BASF AKTIENGESELLSCHAFT (DE) 2001-03-20 US disclosed
US-6057283-A REACTING AN EPOXIDIZED FATTY AMIDE WITH ATLEST A CARBOXYALKYL AMINE OR SULFOALKYL AMINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed
US-6004923-A ANTISOILANTS; DEGREASING NONTEXTILE MATERIALS BASF AKTIENGESELLSCHAFT (DE) 1999-12-21 US disclosed
EP-0874802-A1 FATTY ACID DERIVATIVES AND THE USE THEREOF AS SURFACE ACTIVE AGENTS IN WASHING AND CLEANING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1998-11-04 EP disclosed
WO-1997016408-A1 FATTY ACID DERIVATIVES AND THE USE THEREOF AS SURFACE ACTIVE AGENTS IN WASHING AND CLEANING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1997-05-09 WO disclosed
EP-0387381-A1 Process for producing unsaturated dicarboxylic acid imide compound MATSUSHITA ELECTRIC WORKS, LTD. (JP) 1990-09-19 EP disclosed
US-4134842-A Molded plastic bearing assembly KAMATICS CORPORATION (US) 1979-01-16 US disclosed
US-4053665-A MOLDED PLASTIC BEARING ASSEMBLY KAMATICS CORPORATION (US) 1977-10-11 US disclosed
US-4048370-A Shaped bearing member KAMATICS CORPORATION (US) 1977-09-13 US disclosed